Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Real-time Price Updates for Johnson & Johnson (JNJ-N), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Solid results weren't impressive enough to move the stock price higher.

JNJ stock is on track to rally higher after better-than-expected results. Cash flow and growth say this dividend story is ...

Johnson & Johnson (NYSE:JNJ) has transformed from a slow-growth conglomerate into a pure play in innovative medicine and ...

Johnson & Johnson's growth rate improved this past year, and that trend is likely to continue. The company sees a lot of growth ahead, particularly in its oncology business. 10 stocks we like better ...

Johnson & Johnson is facing lawsuits, patent cliffs, and disruptive drug pricing negotiations. Despite that, the company's ...

Johnson & Johnson is rated Hold, reflecting its defensive profile, strong balance sheet, and fair-to-slight overvaluation per Monte Carlo DCF analysis. JNJ ranks second in peer group quality, with ...

Johnson & Johnson (NYSE:JNJ) declared its 64th consecutive annual dividend increase on April 14, 2026, lifting its quarterly payout from $1.30 per share to $1.34 per share, a 3% increase. The new ...